《DPI：2022Q4癌症疫苗产业概况报告（英文版）（80页）.pdf》由会员分享，可在线阅读，更多相关《DPI：2022Q4癌症疫苗产业概况报告（英文版）（80页）.pdf（80页珍藏版）》请在三个皮匠报告上搜索。

1、Q4 2022Cancer Vaccine Industrywww.deep-pharma.techinfodeep-pharma.techOverview Introduction and Mindmaps3Level of Cancer Vaccine Innovation of 30 Leading Companies in Drug Discovery Sector9Neoantigen Platform14Key Players21SWOT Analysis25Tumour-Associated Antigens Platform26Key Players31SWOT Analysi

2、s34Cellular Platform35Key Players41SWOT Analysis44Table of ContentsAntigenic Essence Platform45Key Players48SWOT Analysis51Oncolytic Viruses Platform52Key Players55SWOT Analysis60Cancer Vaccines Delivery Systems61Key Players65Key Takeaways and General Conclusions 71General Conclusions74Overview of P

3、roprietary Analytics by Deep Pharma Intelligence75Disclaimer803Deep Pharma IntelligenceThe most powerful weapon against malignancies can be hidden inside the host human body,and it is called immune system.Cancer mechanisms usually trick our immune system,but a proper therapy can turn our immunity ba

4、ck against the tumour.This is the aim of cancer vaccination to activate host immunity cells to destroy the tumour cells.A number of FDA-approved vaccines are cancer prevention vaccines,proving that cancer vaccines are more than just a pipe dream.Researchers nowadays are developing vaccines with the

5、goal of reliably and effectively inducing the immune system to target cancer cells.Additionally,they are looking into additional strategies to improve the immune systems response to malignant cells.Tumour-Associated AntigensCellularOncolytic VirusesCancer Vaccine PlatformsNeoantigensAntigenic Essenc

6、eIntro:What is a Cancer Vaccine?Neoantigen PlatformDeveloping vaccines based on specific class of antigens which include those created by tumour viruses that have integrated into the genome and those produced by mutant proteins.They are abundantly expressed only in cancer cells and have a high immun